Search research articles
Contact Us
Filters
Showing results (71-80 of 236) with videos related to
Page
of 24
Sort By:
Molecular and Cellular Biology
|
February 18, 2004
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
Michelle A Booden, Lynn B Eckert, Channing J Der, et al.
Journal of Molecular Signaling
|
July 27, 2010
Transformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways
Anurag Singh, José L Boyer, Channing J Der, et al.
Breast Cancer Research and Treatment
|
March 5, 2004
Molecular basis for Rho GTPase signaling specificity
Antoine E Karnoub, Marc Symons, Sharon L Campbell, et al.
Current Biology : CB
|
November 24, 2004
Atypical mechanism of regulation of the Wrch-1 Rho family small GTPase
Adam Shutes, Anastacia C Berzat, Adrienne D Cox, et al.
Molecular Cancer Research : MCR
|
January 7, 2005
Vav transformation requires activation of multiple GTPases and regulation of gene expression
Todd R Palmby, Karon Abe, Antoine E Karnoub, et al.
Journal of Molecular Signaling
|
August 18, 2009
Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition
Ariella B Hanker, Kevin D Healy, Jean Nichols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2014
Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers
Nicole M Baker, Hoi Yee Chow, Jonathan Chernoff, et al.
Critical Reviews in Biochemistry and Molecular Biology
|
August 26, 2020
RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Richard G Hodge, Antje Schaefer, Sarah V Howard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?
Patrick J Roberts, Thomas E Stinchcombe, Channing J Der, et al.
Biochimica Et Biophysica Acta
|
September 16, 2014
Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame
Leanna R Gentry, Timothy D Martin, David J Reiner, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 236) with videos related to
Sort By:
Page
of 24
Molecular and Cellular Biology
|
February 18, 2004
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
Michelle A Booden, Lynn B Eckert, Channing J Der, et al.
Journal of Molecular Signaling
|
July 27, 2010
Transformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways
Anurag Singh, José L Boyer, Channing J Der, et al.
Breast Cancer Research and Treatment
|
March 5, 2004
Molecular basis for Rho GTPase signaling specificity
Antoine E Karnoub, Marc Symons, Sharon L Campbell, et al.
Current Biology : CB
|
November 24, 2004
Atypical mechanism of regulation of the Wrch-1 Rho family small GTPase
Adam Shutes, Anastacia C Berzat, Adrienne D Cox, et al.
Molecular Cancer Research : MCR
|
January 7, 2005
Vav transformation requires activation of multiple GTPases and regulation of gene expression
Todd R Palmby, Karon Abe, Antoine E Karnoub, et al.
Journal of Molecular Signaling
|
August 18, 2009
Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition
Ariella B Hanker, Kevin D Healy, Jean Nichols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2014
Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers
Nicole M Baker, Hoi Yee Chow, Jonathan Chernoff, et al.
Critical Reviews in Biochemistry and Molecular Biology
|
August 26, 2020
RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Richard G Hodge, Antje Schaefer, Sarah V Howard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?
Patrick J Roberts, Thomas E Stinchcombe, Channing J Der, et al.
Biochimica Et Biophysica Acta
|
September 16, 2014
Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame
Leanna R Gentry, Timothy D Martin, David J Reiner, et al.
Page
of 24